Literature DB >> 12682336

Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease.

H Kanno1, I Yamamoto, M Yoshida, H Kitamura.   

Abstract

The genetic mechanism of the tumorigenesis of meningioma in conjunction with von Hippel-Lindau (VHL) disease is unclear. The authors present a case of VHL disease associated with a posterior fossa meningioma and with multiple cerebellar hemangioblastomas. A germline mutation of the VHL gene and loss of heterozygosity on the VHL gene locus in 3p were detected in the meningioma. Tumorigenesis of a meningioma associated with VHL disease could be caused by inactivation of both alleles of the VHL gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682336     DOI: 10.1212/01.wnl.0000055866.64240.2e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma.

Authors:  Yoyo Wing-Yiu Chu; Daniel Ka Leung Cheuk; Brian Hon Yin Chung; Naomi L Bowers; Shau-Yin Ha; Alan Kwok-Shing Chiang; Godfrey Chi-Fung Chan
Journal:  BMJ Case Rep       Date:  2014-11-18

Review 2.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  Falcine meningioma in Von Hippel-Lindau disease: An unusual association.

Authors:  Domenico Murrone; Bruno Romanelli; Nicola Montemurro; Domenico Chirchiglia; Aldo Ierardi
Journal:  Surg Neurol Int       Date:  2018-02-14

4.  Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases.

Authors:  Yuanliang Wang; Guobiao Liang; Jing Tian; Xin Wang; Anjian Chen; Tiancai Liang; Yang Du; Hao Li; Jiang Du; Lang Yu; Zongping Chen
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.